6533b7cffe1ef96bd1258ec6
RESEARCH PRODUCT
Reply to: Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials (Galvano et al., J Bone Oncol 2019; 18:100252)
Giulia Letizia MauroDalila ScaturroAntonio GalvanoAntonio RussoViviana Bazansubject
Oncologymedicine.medical_specialtylcsh:Diseases of the musculoskeletal systembusiness.industryMEDLINEEndocrine therapylcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaselcsh:RC254-282Bone healthlaw.inventionBreast cancermedicine.anatomical_structureDenosumabOncologyRandomized controlled triallawProstateMeta-analysisInternal medicineCommentarymedicinelcsh:RC925-935businessmedicine.drugyear | journal | country | edition | language |
---|---|---|---|---|
2020-06-01 | Journal of Bone Oncology |